A process for the recovery of strontium from the urine of patients injected with 89Sr.
89Sr is a beta emitter used for palliation of pain in patients with metastatic bone cancer. After each intravenous administration, up to 80% of the isotope is eliminated in the urine. A simple chemical process is described, which permits the recovery and purification of the 89Sr from the urine.
Argiro
G
G
Department of Nuclear Medicine, S. Eugenio Hospital, Rome, Italy.
Atzei
G
G
Boemi
S
S
Cipriani
C
C
Shukla
S K
SK
Rossi
G
G
Sedda
A F
AF
D001859:Bone Neoplasms / Q000532:radiotherapy; D006801:Humans; D010146:Pain / Q000532:radiotherapy; D010166:Palliative Care; D013324:Strontium / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D013326:Strontium Radioisotopes / Q000302:isolation & purification / Q000627:therapeutic use* / Q000652:urine*
D013326:Strontium Radioisotopes; C025700:strontium chloride; D013324:Strontium